[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 4, 1983

Dealing With Alleged Fraud in Medical Research

Author Affiliations

President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research Washington, DC

JAMA. 1983;249(9):1150. doi:10.1001/jama.1983.03330330032019
Abstract

To the Editor.—  The recent editorial, "Dealing With Alleged Fraud in Medical Research" (JAMA 1982;248:1637), struck a responsive chord at the President's Commission. We are pleased with the endorsement of assigning responsibility to clinical investigators and research administrators for upholding, by declaration and example, the highest ethical standards for conducting biomedical research.The President's Commission has recently issued two reports on this subject. The 1981 Biennial Report, "Protecting Human Subjects,"1 contains recommendations for improving the response of research institutions, professional societies, and funding agencies to reports of misconduct in biomedical research. Those recommendations were, in turn derived from a two-day conference held in September 1981 under the joint sponsorship of the President's Commission, the American Association for the Advancement of Science Committee on Scientific Freedom and Responsibility, and Medicine in the Public Interest. The published proceedings of that conference, "Whistle-blowing in Biomedical Research,"2 are available through the Commission

×